NEW YORK (dpa-AFX) – The record run on the US stock exchanges continued with small steps on Tuesday. Only the Dow Jones Industrial is still lagging behind. Around two hours before the close of trading, the world’s most famous Wall Street index rose by a low 0.07 percent to 34,308.16 points. Its moderate profits at the start of trading have largely crumbled.
The market-wide S&P 500 stepped on the spot with a plus of 0.03 percent to 4291.94 points, after having broken the 4300 point mark in early trading for the first time in its history. Likewise, the Nasdaq stock exchanges, which are mainly peppered with technology stocks, topped their records and were able to hold them. The selection index Nasdaq 100 recently advanced by 0.20 percent to 14,553.51 points.
The economic data hardly moved. The real estate market continues to record strong price increases. In addition, the mood of US consumers surprisingly brightened significantly and rose again to the level shortly before the Corona crisis. “Even if the mood recovery is impressive, it is only partially reflected in the spending behavior of consumers,” said market analyst Michael Hewson from CMC Markets and recalled the fall in retail sales in May.
On the corporate side, the focus was primarily on the banking sector. The leading Wall Street banks want to distribute more money to shareholders after passing the stress test. Morgan Stanley wants to double the quarterly dividend to 70 US cents and use up to twelve billion dollars for share buybacks. The papers rose in the S&P 100 by 3.6 percent.
Dow members Goldman Sachs and JPMorgan are also looking to hike their dividends, which brought Goldman shares up 1.2 percent while JPMorgan shares’ earnings vanished into thin air. Citigroup’s paper, which does not want to change its previous plans for the time being, also lost 1.8 percent.
The focus also shifted to the share of Moderna, which jumped to a record high and most recently showed an increase of 5.7 percent at the top of the Nasdaq 100. It benefited from the fact that India has now also approved the US biotech company’s corona vaccine. In addition, according to the company, the Moderna vaccine also stimulates an immune response against the Corona variant Delta (B.1.617.2), which first appeared in India./ck/men
– –
